Cardinal Health highlights visibility and Cardinal Health stock costs EUR 208.55
Published on 10/08/2026 at 16:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Cardinal Health (ISIN US14149Y1082) was trading at EUR 208.55 at Lang & Schwarz on October 8, 2026 at 4:00 p.m. CEST, up 0.58 percent versus the EUR 207.35 prior close. On October 8, Cardinal Health highlighted real-time visibility and data-driven intervention through its OptiFreight Logistics business.
Visibility moves beyond logistics
The October 8 article described visibility as a tool for identifying shipment risks early and coordinating intervention for time-sensitive medicines and biologics. That places technology, data quality and logistics expertise alongside physical distribution in Cardinal Health's healthcare offering.
Fiscal 2026 revenue reached USD 254.25 billion, up 14.23 percent from USD 222.58 billion in fiscal 2025, according to StockAnalysis. Net income was USD 1.71 billion in fiscal 2026, compared with USD 1.56 billion in fiscal 2025.
What does the CVS extension mean?
The more measurable operating signal came on October 1, when Cardinal Health said it had entered a binding letter of intent to extend its pharmaceutical distribution agreements with CVS Health through June 30, 2032. The same release reaffirmed fiscal 2027 non-GAAP earnings per share guidance of USD 12.40-12.60, equivalent to 13 percent to 15 percent growth based on adjusted fiscal 2026 results excluding an IEEPA tariff refund.
Three dates frame the story
On August 11, 2026, Cardinal Health reported fiscal 2026 revenue of USD 254.25 billion, up from USD 222.58 billion in fiscal 2025. On October 1, 2026, it set the CVS distribution extension through June 30, 2032 and reaffirmed the USD 12.40-12.60 guidance range. On October 8, 2026, its supply-chain article put real-time visibility and OptiFreight Logistics at the center of its operating message.
Upcoming reporting date
Cardinal Health has scheduled its first-quarter fiscal 2027 results for November 5, 2026, before trading begins on the New York Stock Exchange, according to the October 1 release. The CVS distribution agreement is scheduled to run through June 30, 2032.
Stock stays below its yearly high
The finance snapshot places Cardinal Health at a market capitalization of USD 54.7 billion on October 8, 2026, with a 52-week range of USD 151.87 to USD 258.30. The primary listing is on the New York Stock Exchange, where the stock was last quoted at USD 233.40 at 2:00 p.m. UTC on October 8, 2026.
The further course of trading is shown by the continuously updated real-time quote of Cardinal Health stock.
Cardinal Health stock facts
- Company: Cardinal Health, Inc.
- ISIN: US14149Y1082
- Ticker: CAH
- Primary exchange: New York Stock Exchange
- Price Lang & Schwarz (as of October 8, 2026, 4:00 p.m. CEST): EUR 208.55
- Change versus prior close: plus 0.58 percent
- Prior close Lang & Schwarz (October 7, 2026): EUR 207.35
- Market capitalization: USD 54.7 billion (as of October 8, 2026)
- 52-week range: USD 151.87-258.30 (as of October 8, 2026)
- Sector / Industry: Healthcare / Medical Distribution
- Index membership: S&P 500
- Next earnings date: November 5, 2026
Market context: Market report S&P 500.
